Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & EnergyDetailed TOC of Global Nanocarrier-Based Vaccine Market Research Report 2024
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nanocarrier-Based Vaccine Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Adjuvants
1.2.3 Delivery Systems
1.3 Market by Application
1.3.1 Global Nanocarrier-Based Vaccine Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nanocarrier-Based Vaccine Market Perspective (2019-2030)
2.2 Nanocarrier-Based Vaccine Growth Trends by Region
2.2.1 Global Nanocarrier-Based Vaccine Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Nanocarrier-Based Vaccine Historic Market Size by Region (2019-2024)
2.2.3 Nanocarrier-Based Vaccine Forecasted Market Size by Region (2025-2030)
2.3 Nanocarrier-Based Vaccine Market Dynamics
2.3.1 Nanocarrier-Based Vaccine Industry Trends
2.3.2 Nanocarrier-Based Vaccine Market Drivers
2.3.3 Nanocarrier-Based Vaccine Market Challenges
2.3.4 Nanocarrier-Based Vaccine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nanocarrier-Based Vaccine Players by Revenue
3.1.1 Global Top Nanocarrier-Based Vaccine Players by Revenue (2019-2024)
3.1.2 Global Nanocarrier-Based Vaccine Revenue Market Share by Players (2019-2024)
3.2 Global Nanocarrier-Based Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nanocarrier-Based Vaccine Revenue
3.4 Global Nanocarrier-Based Vaccine Market Concentration Ratio
3.4.1 Global Nanocarrier-Based Vaccine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nanocarrier-Based Vaccine Revenue in 2023
3.5 Nanocarrier-Based Vaccine Key Players Head office and Area Served
3.6 Key Players Nanocarrier-Based Vaccine Product Solution and Service
3.7 Date of Enter into Nanocarrier-Based Vaccine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nanocarrier-Based Vaccine Breakdown Data by Type
4.1 Global Nanocarrier-Based Vaccine Historic Market Size by Type (2019-2024)
4.2 Global Nanocarrier-Based Vaccine Forecasted Market Size by Type (2025-2030)
5 Nanocarrier-Based Vaccine Breakdown Data by Application
5.1 Global Nanocarrier-Based Vaccine Historic Market Size by Application (2019-2024)
5.2 Global Nanocarrier-Based Vaccine Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Nanocarrier-Based Vaccine Market Size (2019-2030)
6.2 North America Nanocarrier-Based Vaccine Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Nanocarrier-Based Vaccine Market Size by Country (2019-2024)
6.4 North America Nanocarrier-Based Vaccine Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nanocarrier-Based Vaccine Market Size (2019-2030)
7.2 Europe Nanocarrier-Based Vaccine Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Nanocarrier-Based Vaccine Market Size by Country (2019-2024)
7.4 Europe Nanocarrier-Based Vaccine Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nanocarrier-Based Vaccine Market Size (2019-2030)
8.2 Asia-Pacific Nanocarrier-Based Vaccine Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Nanocarrier-Based Vaccine Market Size by Region (2019-2024)
8.4 Asia-Pacific Nanocarrier-Based Vaccine Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nanocarrier-Based Vaccine Market Size (2019-2030)
9.2 Latin America Nanocarrier-Based Vaccine Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Nanocarrier-Based Vaccine Market Size by Country (2019-2024)
9.4 Latin America Nanocarrier-Based Vaccine Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nanocarrier-Based Vaccine Market Size (2019-2030)
10.2 Middle East & Africa Nanocarrier-Based Vaccine Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Nanocarrier-Based Vaccine Market Size by Country (2019-2024)
10.4 Middle East & Africa Nanocarrier-Based Vaccine Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Emergent BioSolutions
11.1.1 Emergent BioSolutions Company Detail
11.1.2 Emergent BioSolutions Business Overview
11.1.3 Emergent BioSolutions Nanocarrier-Based Vaccine Introduction
11.1.4 Emergent BioSolutions Revenue in Nanocarrier-Based Vaccine Business (2019-2024)
11.1.5 Emergent BioSolutions Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Detail
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Nanocarrier-Based Vaccine Introduction
11.2.4 Sanofi Revenue in Nanocarrier-Based Vaccine Business (2019-2024)
11.2.5 Sanofi Recent Development
11.3 GlaxoSmithKline Biologicals
11.3.1 GlaxoSmithKline Biologicals Company Detail
11.3.2 GlaxoSmithKline Biologicals Business Overview
11.3.3 GlaxoSmithKline Biologicals Nanocarrier-Based Vaccine Introduction
11.3.4 GlaxoSmithKline Biologicals Revenue in Nanocarrier-Based Vaccine Business (2019-2024)
11.3.5 GlaxoSmithKline Biologicals Recent Development
11.4 Merck
11.4.1 Merck Company Detail
11.4.2 Merck Business Overview
11.4.3 Merck Nanocarrier-Based Vaccine Introduction
11.4.4 Merck Revenue in Nanocarrier-Based Vaccine Business (2019-2024)
11.4.5 Merck Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Nanocarrier-Based Vaccine Introduction
11.5.4 Pfizer Revenue in Nanocarrier-Based Vaccine Business (2019-2024)
11.5.5 Pfizer Recent Development
11.6 Novartis
11.6.1 Novartis Company Detail
11.6.2 Novartis Business Overview
11.6.3 Novartis Nanocarrier-Based Vaccine Introduction
11.6.4 Novartis Revenue in Nanocarrier-Based Vaccine Business (2019-2024)
11.6.5 Novartis Recent Development
11.7 Moderna
11.7.1 Moderna Company Detail
11.7.2 Moderna Business Overview
11.7.3 Moderna Nanocarrier-Based Vaccine Introduction
11.7.4 Moderna Revenue in Nanocarrier-Based Vaccine Business (2019-2024)
11.7.5 Moderna Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global Nanocarrier-Based Vaccine Market Research Report 2024
List of TablesTable 1. Global Nanocarrier-Based Vaccine Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Adjuvants
Table 3. Key Players of Delivery Systems
Table 4. Global Nanocarrier-Based Vaccine Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Nanocarrier-Based Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Nanocarrier-Based Vaccine Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Nanocarrier-Based Vaccine Market Share by Region (2019-2024)
Table 8. Global Nanocarrier-Based Vaccine Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Nanocarrier-Based Vaccine Market Share by Region (2025-2030)
Table 10. Nanocarrier-Based Vaccine Market Trends
Table 11. Nanocarrier-Based Vaccine Market Drivers
Table 12. Nanocarrier-Based Vaccine Market Challenges
Table 13. Nanocarrier-Based Vaccine Market Restraints
Table 14. Global Nanocarrier-Based Vaccine Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Nanocarrier-Based Vaccine Market Share by Players (2019-2024)
Table 16. Global Top Nanocarrier-Based Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanocarrier-Based Vaccine as of 2023)
Table 17. Ranking of Global Top Nanocarrier-Based Vaccine Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Nanocarrier-Based Vaccine Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Nanocarrier-Based Vaccine Product Solution and Service
Table 21. Date of Enter into Nanocarrier-Based Vaccine Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Nanocarrier-Based Vaccine Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Nanocarrier-Based Vaccine Revenue Market Share by Type (2019-2024)
Table 25. Global Nanocarrier-Based Vaccine Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Nanocarrier-Based Vaccine Revenue Market Share by Type (2025-2030)
Table 27. Global Nanocarrier-Based Vaccine Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Nanocarrier-Based Vaccine Revenue Market Share by Application (2019-2024)
Table 29. Global Nanocarrier-Based Vaccine Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Nanocarrier-Based Vaccine Revenue Market Share by Application (2025-2030)
Table 31. North America Nanocarrier-Based Vaccine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Nanocarrier-Based Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Nanocarrier-Based Vaccine Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Nanocarrier-Based Vaccine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Nanocarrier-Based Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Nanocarrier-Based Vaccine Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Nanocarrier-Based Vaccine Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Nanocarrier-Based Vaccine Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Nanocarrier-Based Vaccine Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Nanocarrier-Based Vaccine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Nanocarrier-Based Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Nanocarrier-Based Vaccine Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Nanocarrier-Based Vaccine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Nanocarrier-Based Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Nanocarrier-Based Vaccine Market Size by Country (2025-2030) & (US$ Million)
Table 46. Emergent BioSolutions Company Detail
Table 47. Emergent BioSolutions Business Overview
Table 48. Emergent BioSolutions Nanocarrier-Based Vaccine Product
Table 49. Emergent BioSolutions Revenue in Nanocarrier-Based Vaccine Business (2019-2024) & (US$ Million)
Table 50. Emergent BioSolutions Recent Development
Table 51. Sanofi Company Detail
Table 52. Sanofi Business Overview
Table 53. Sanofi Nanocarrier-Based Vaccine Product
Table 54. Sanofi Revenue in Nanocarrier-Based Vaccine Business (2019-2024) & (US$ Million)
Table 55. Sanofi Recent Development
Table 56. GlaxoSmithKline Biologicals Company Detail
Table 57. GlaxoSmithKline Biologicals Business Overview
Table 58. GlaxoSmithKline Biologicals Nanocarrier-Based Vaccine Product
Table 59. GlaxoSmithKline Biologicals Revenue in Nanocarrier-Based Vaccine Business (2019-2024) & (US$ Million)
Table 60. GlaxoSmithKline Biologicals Recent Development
Table 61. Merck Company Detail
Table 62. Merck Business Overview
Table 63. Merck Nanocarrier-Based Vaccine Product
Table 64. Merck Revenue in Nanocarrier-Based Vaccine Business (2019-2024) & (US$ Million)
Table 65. Merck Recent Development
Table 66. Pfizer Company Detail
Table 67. Pfizer Business Overview
Table 68. Pfizer Nanocarrier-Based Vaccine Product
Table 69. Pfizer Revenue in Nanocarrier-Based Vaccine Business (2019-2024) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. Novartis Company Detail
Table 72. Novartis Business Overview
Table 73. Novartis Nanocarrier-Based Vaccine Product
Table 74. Novartis Revenue in Nanocarrier-Based Vaccine Business (2019-2024) & (US$ Million)
Table 75. Novartis Recent Development
Table 76. Moderna Company Detail
Table 77. Moderna Business Overview
Table 78. Moderna Nanocarrier-Based Vaccine Product
Table 79. Moderna Revenue in Nanocarrier-Based Vaccine Business (2019-2024) & (US$ Million)
Table 80. Moderna Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nanocarrier-Based Vaccine Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Nanocarrier-Based Vaccine Market Share by Type: 2023 VS 2030
Figure 3. Adjuvants Features
Figure 4. Delivery Systems Features
Figure 5. Global Nanocarrier-Based Vaccine Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Nanocarrier-Based Vaccine Market Share by Application: 2023 VS 2030
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Other Case Studies
Figure 10. Nanocarrier-Based Vaccine Report Years Considered
Figure 11. Global Nanocarrier-Based Vaccine Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Nanocarrier-Based Vaccine Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Nanocarrier-Based Vaccine Market Share by Region: 2023 VS 2030
Figure 14. Global Nanocarrier-Based Vaccine Market Share by Players in 2023
Figure 15. Global Top Nanocarrier-Based Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanocarrier-Based Vaccine as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Nanocarrier-Based Vaccine Revenue in 2023
Figure 17. North America Nanocarrier-Based Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Nanocarrier-Based Vaccine Market Share by Country (2019-2030)
Figure 19. United States Nanocarrier-Based Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Nanocarrier-Based Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Nanocarrier-Based Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Nanocarrier-Based Vaccine Market Share by Country (2019-2030)
Figure 23. Germany Nanocarrier-Based Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Nanocarrier-Based Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Nanocarrier-Based Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Nanocarrier-Based Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Nanocarrier-Based Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Nanocarrier-Based Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Nanocarrier-Based Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Nanocarrier-Based Vaccine Market Share by Region (2019-2030)
Figure 31. China Nanocarrier-Based Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Nanocarrier-Based Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Nanocarrier-Based Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Nanocarrier-Based Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Nanocarrier-Based Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Nanocarrier-Based Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Nanocarrier-Based Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Nanocarrier-Based Vaccine Market Share by Country (2019-2030)
Figure 39. Mexico Nanocarrier-Based Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Nanocarrier-Based Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Nanocarrier-Based Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Nanocarrier-Based Vaccine Market Share by Country (2019-2030)
Figure 43. Turkey Nanocarrier-Based Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Nanocarrier-Based Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Emergent BioSolutions Revenue Growth Rate in Nanocarrier-Based Vaccine Business (2019-2024)
Figure 46. Sanofi Revenue Growth Rate in Nanocarrier-Based Vaccine Business (2019-2024)
Figure 47. GlaxoSmithKline Biologicals Revenue Growth Rate in Nanocarrier-Based Vaccine Business (2019-2024)
Figure 48. Merck Revenue Growth Rate in Nanocarrier-Based Vaccine Business (2019-2024)
Figure 49. Pfizer Revenue Growth Rate in Nanocarrier-Based Vaccine Business (2019-2024)
Figure 50. Novartis Revenue Growth Rate in Nanocarrier-Based Vaccine Business (2019-2024)
Figure 51. Moderna Revenue Growth Rate in Nanocarrier-Based Vaccine Business (2019-2024)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
REQUEST COMPANIES MENTIONED IN THIS REPORT
